1)(CLSI)CaLSI:Performance Standards for Antimicrobial Susceptibility Testing M100-Ed31. Wayne:CLSI, 2021
2)JANIS:厚生労働省院内感染対策サーベイランス事業 https://janis.mhlw.go.jp/(2022年2月閲覧)
3)Tunkel AR, et al:Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267-1284, 2004
4)Corredoira-Sanchez J, et al:Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus(Streptococcus bovis I)and colorectal neoplasia;A case-control study. Clin Infect Dis 55:491-496, 2012
5)Baddour LM, et al:Infective endocarditis in adults;Diagnosis, antimicrobial therapy, and management of complications;A scientific statement for healthcare professionals from the American Heart Association. Circulation 132:1435-1486, 2015
6)Tunkel AR, Sepkowitz KA:Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34:1524-1529, 2002
7)Lancefield RC:A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 57:571-595, 1933
8)Stevens DL, et al:Practice guidelines for the diagnosis and management of skin and soft tissue infections;2014 update by the infectious diseases society of america. Clin Infect Dis 59:e10-52, 2014
9)Francois Watkins LK, et al:Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008-2016. JAMA Intern Med 179:479-488, 2019
10)Kimura K, et al:First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 52:2890-2897, 2008
11)Nishiyama N, et al:Clinical and bacterial features of Group B streptococci with reduced penicillin susceptibility from respiratory specimens;A case-control study. Eur J Clin Microbiol Infect Dis 41:1-8, 2022
12)Baracco GJ:Infections caused by group C and G streptococcus(streptococcus dysgalactiae subsp. equisimilis and Others);Epidemiological and clinical aspects. Microbiol Spectr 7, 2019